93 related articles for article (PubMed ID: 10692738)
1. Attention deficit hyperactivity disorder: possible causes and treatment.
Gordon N
Int J Clin Pract; 1999; 53(7):524-8. PubMed ID: 10692738
[TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
3. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
4. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
5. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
6. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
7. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
[TBL] [Abstract][Full Text] [Related]
8. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
't Jong GW; van den Anker JN
Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
[No Abstract] [Full Text] [Related]
9. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
[TBL] [Abstract][Full Text] [Related]
10. New options in the pharmacological management of attention-deficit/hyperactivity disorder.
Olfson M
Am J Manag Care; 2004 Jul; 10(4 Suppl):S117-24. PubMed ID: 15352538
[TBL] [Abstract][Full Text] [Related]
11. Stimulant therapy in attention deficit/hyperactivity disorder.
Baldwin RL
J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
[TBL] [Abstract][Full Text] [Related]
12. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry.
Teicher MH; Anderson CM; Polcari A; Glod CA; Maas LC; Renshaw PF
Nat Med; 2000 Apr; 6(4):470-3. PubMed ID: 10742158
[TBL] [Abstract][Full Text] [Related]
13. Attention-deficit/hyperactivity disorder: management.
Szymanski ML; Zolotor A
Am Fam Physician; 2001 Oct; 64(8):1355-62. PubMed ID: 11681777
[TBL] [Abstract][Full Text] [Related]
14. [Attention deficit syndrome. Basic aspects of its diagnosis and treatment].
Arriada-Mendicoa N; Otero-Siliceo E
Rev Neurol; 2000 Nov 1-15; 31(9):845-51. PubMed ID: 11127088
[TBL] [Abstract][Full Text] [Related]
15. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
16. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
17. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Visser SN; Lesesne CA; Perou R
Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
[TBL] [Abstract][Full Text] [Related]
18. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
[TBL] [Abstract][Full Text] [Related]
20. Clinical review: evidence-based diagnosis and treatment of ADHD in children.
Nair J; Ehimare U; Beitman BD; Nair SS; Lavin A
Mo Med; 2006; 103(6):617-21. PubMed ID: 17256270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
